DK3438096T3 - Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner - Google Patents

Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner Download PDF

Info

Publication number
DK3438096T3
DK3438096T3 DK17773281.5T DK17773281T DK3438096T3 DK 3438096 T3 DK3438096 T3 DK 3438096T3 DK 17773281 T DK17773281 T DK 17773281T DK 3438096 T3 DK3438096 T3 DK 3438096T3
Authority
DK
Denmark
Prior art keywords
arylmethyl
diones
quinazoline
preparation
Prior art date
Application number
DK17773281.5T
Other languages
English (en)
Inventor
Suixiong Cai
Ping Huang
Original Assignee
Impact Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Impact Therapeutics Inc filed Critical Impact Therapeutics Inc
Application granted granted Critical
Publication of DK3438096T3 publication Critical patent/DK3438096T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D9/00—Crystallisation
    • B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK17773281.5T 2016-04-01 2017-03-31 Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner DK3438096T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610202881 2016-04-01
PCT/CN2017/078913 WO2017167251A1 (zh) 2016-04-01 2017-03-31 1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮的制备工艺

Publications (1)

Publication Number Publication Date
DK3438096T3 true DK3438096T3 (da) 2021-02-22

Family

ID=59963547

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17773281.5T DK3438096T3 (da) 2016-04-01 2017-03-31 Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner

Country Status (13)

Country Link
US (1) US10562889B2 (da)
EP (1) EP3438096B1 (da)
CN (1) CN109153652B (da)
CY (1) CY1123898T1 (da)
DK (1) DK3438096T3 (da)
ES (1) ES2859460T3 (da)
HR (1) HRP20210328T1 (da)
HU (1) HUE053554T2 (da)
PL (1) PL3438096T3 (da)
PT (1) PT3438096T (da)
RS (1) RS61556B1 (da)
SI (1) SI3438096T1 (da)
WO (1) WO2017167251A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022099442A1 (zh) * 2020-11-10 2022-05-19 上海瑛派药业有限公司 5-氟-1-(4-氟-3-(4-(嘧啶-2-基)哌嗪-1-羰基)苄基)喹唑啉-2,4(1h,3h)-二酮的结晶形式及其制备

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070010671A1 (en) * 2003-03-31 2007-01-11 Yoshinori Sekiguchi Novel quinazoline derivatives and methods of treatment related to the use thereof
ES2415771T3 (es) * 2004-06-30 2013-07-26 Janssen Pharmaceutica N.V. Derivados de quinazolina como inhibidores de PARP
AU2005282761B2 (en) * 2004-09-02 2012-02-02 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
CN101475537A (zh) * 2009-01-07 2009-07-08 太仓市浦源化工有限公司 一种2,4-二氯喹唑啉的制备方法
WO2012125521A1 (en) * 2011-03-14 2012-09-20 Eternity Bioscience Inc. Quinazolinediones and their use
TWI527800B (zh) * 2011-04-01 2016-04-01 南京英派藥業有限公司 作為聚（二磷酸腺苷酸－核醣）聚合酶（ｐａｒｐ）之抑制劑之１－（芳基甲基）喹唑啉－２，４（１ｈ，３ｈ）－二酮及其應用
WO2013064083A1 (en) * 2011-11-01 2013-05-10 Impact Therapeutics, Inc. 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof
CA2981627C (en) * 2015-04-03 2024-02-20 Suixiong Cai Solid pharmaceutical formulation of parp inhibitors and the use thereof
US20190006601A1 (en) * 2015-12-21 2019-01-03 Idemitsu Kosan Co., Ltd. Nitrogen-containing heterocyclic compounds and organic electroluminescence devices containing them

Also Published As

Publication number Publication date
ES2859460T3 (es) 2021-10-04
US20190112298A1 (en) 2019-04-18
WO2017167251A1 (zh) 2017-10-05
CY1123898T1 (el) 2022-05-27
EP3438096A4 (en) 2019-08-21
US10562889B2 (en) 2020-02-18
HUE053554T2 (hu) 2021-07-28
EP3438096B1 (en) 2020-12-02
PL3438096T3 (pl) 2021-05-17
PT3438096T (pt) 2021-03-03
SI3438096T1 (sl) 2021-04-30
CN109153652B (zh) 2021-07-27
EP3438096A1 (en) 2019-02-06
RS61556B1 (sr) 2021-04-29
CN109153652A (zh) 2019-01-04
HRP20210328T1 (hr) 2021-04-02

Similar Documents

Publication Publication Date Title
MA47433A (fr) Composé de quinazoline
MA51771A (fr) Procédés de préparation de (1-(3-fluoro-2-(trifluorométhyl)isonicotinyl)pipéridine-4-one)
ZA201801534B (en) New uses of 2-(2,4-dichlorophenyl)methyl-4,4-dimethyl-3-isoxazolidone as foliar herbicide
DK3509811T3 (da) Fremgangsmåde til fremstilling af polyolefin-recyklater
EP3246328A4 (en) Quinazoline heterocyclic compound as egfr kinase inhibitor, and preparation and application thereof
DK3488028T3 (da) Fremgangsmåde til elektrokemisk fremstilling af ammoniak
DK3497081T3 (da) Fremgangsmåde til fremstilling af 4-ammonium-2,2,6,6-tetraalkylpiperidinylsalte
EP3376865A4 (en) 4 - ((6- (2,4-difluorophenyl) -1,1-difluoro-2-HYDROXY-3- (1 H
DK3094178T3 (da) Agrokemisk sammensætning, der omfatter n,n'-diphenyl(thio)urea til forbedring af afgrødeproduktivitet
DK3251523T3 (da) Fremgangsmåde til fremstilling af granuleret tilskudsfoder
DK3114235T3 (da) Fremgangsmåde til bestemmelse af risiko for 5-fluorouracil-toksicitet
DK3432872T3 (da) Eflornithin til anvendelse til behandling af temozolomid tilbagevendende/refraktær anaplastisk astrocytom
DK3105220T3 (da) Fremgangsmåde til fremstilling af pyrimidinsulfamidderivater
DK3717476T3 (da) Fremgangsmåde til fremstilling af 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazol og hydrogensulfatsaltet deraf
EP3448852A4 (en) NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF TYROSINE KINASE BCR-ABL
DK3408015T3 (da) Fremgangsmåde til fremstilling af emulsioner
DK3297631T3 (da) NK-1/NK-3-receptorantagonist til behandling af hedeture
EP3440084A4 (en) KINASE SCAFFOLDING PYRIMIDO-DIAZEPINONE COMPOUNDS AND METHODS FOR TREATING PI3K-INDUCED DISORDERS
DK3487837T3 (da) Fremgangsmåde til fremstilling af spiroheterocykliske pyrrolidindion-herbicider ved hjælp af mellemforbindelsen 2-(4-chlor-2,6-dimethylphenyl)eddikesyre
DK3476838T3 (da) Fremgangsmåde til fremstilling af azoxystrobin
DK3438096T3 (da) Fremgangsmåde til fremstilling af 1-(arylmethyl)quinazolin-2,4-(1H, 3H)-dioner
EA201891430A1 (ru) Твердые формы замещенных 5,6-дигидро-6-фенилбензо[f]изохинолин-2-аминовых соединений
PE20180503A1 (es) 2-tiopirimidinonas
DK3402775T5 (da) Fremgangsmåde til fremstilling af 2-(4-chlor-2,6-dimethylphenyl)ethanol
DK3630729T3 (da) Pyrimidinforbindelse